KONTROLLIERTE FREISETZUNG PHENOLISCHER OPIOIDE

European patent · EP2046393 · In force

Register entry

Publication number
EP2046393
Application number
EP07797745
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 24, 2007
Published
Apr 15, 2009
Granted
Feb 12, 2014
Protection ends at the latest
May 23, 2027
Next annual fee due
May 31, 2027
IPC classes
A61K 47/48 (2006.01)
A61P 25/04 (2006.01)
Priority
US 809082 P 26.05.2006
US 901795 P 16.02.2007
PCT application
PCT/US2007/069683 24.05.2007
PCT publication
WO2007/140272 06.12.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 2, 2023

    Change

    Published in Swissreg on 02.06.2023

  5. Feb 12, 2014

    Granted

    Published in Swissreg on 12.02.2014

Parties

Holder

Signature Therapeutics, Inc.

1731 Embarcadero Road, Suite 200, Palo Alto, CA 94303, US

Inventor

JENKINS, Thomas E.

Half Moon Bay, CA 94019, US

KOLESNIKOV, Aleksandr

San Francisco, California 94121, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.